“Direct cost of potentially inappropriate prescription, according to STOPP/START criteria in geriatric patients with diabetes type 2 hospitalized in a third level institution”, Cienc. Salud Virtual, vol. 12, no. 2, pp. 63–76, Dec. 2020, doi: 10.22519/21455333.1526.